EUDAMED – update on timelines
EUDAMED is one of the key aspects of the new rules on medical devices (Regulation (EU) 2017/745) and in vitro diagnostic medical devices (Regulation (EU) 2017/746), and it is expected to achieve full functionality by the second quarter of 2024.

EUDAMED

EUDAMED will provide a living picture of the lifecycle of medical devices available in the European Union (EU) market, while enhancing the overall transparency through better access to information and facilitating the coordination between EU Member States.

EUDAMED will be composed of six modules:

  • Actor registration;
  • Unique device identification (UDI)/ device registration;
  • Notified bodies and certificates;
  • Clinical investigations and performance studies;
  • Vigilance and Post-Market Surveillance,
  • Market Surveillance

In 2019, the European Commission clarified that EUDAMED will be completely functional only when all the modules are available and after confirmation of the functional specifications by an independent audit.

EUDAMED was originally scheduled to be launched in 2020, but it suffered several delays.

EUDAMED new timeline

On June 2022, the European Commission issued a new timeline planning for the EUDAMED.

Figure 1. EUDAMED new timeline

(adapted from “EUDAMED Timeline – The European Commission planning – June 2022″)

It is expected a minimally viable version of EUDAMED to be developed until the last quarter of 2023. 

The independent audit will be performed on the first two quarters of 2024.

A notice of the fully operationalization of the EUDAMED will be published in the Official Journal of the European Union in the second quarter of 2024.

After the publication of this notice, there is a transitional period of 6 months, which is expected to end by the last quarter of 2024. From that date, EUDAMED becomes mandatory as regards to obligations and requirements related to Actor Registration, Clinical Investigations and Performance Studies, Vigilance and Post-Market Surveillance and Market Surveillance.

All modules of EUDAMED will be mandatory by the second quarter of 2026.

References:

  1. EUDAMED Timeline – The European Commission planning – June 2022.

further
reading

medical devices

EUDAMED – harmonized practices and alternative solutions for IVDR until the database is fully functional

EUDAMED is one of the key aspects of the new rules on in vitro diagnostic medical devices – Regulation (EU) 2017/746. However, it is only expected to achieve full functionality by the second quarter of 2024. Until then, how is the information submitted and/or exchanged between manufacturers, notified bodies and competent authorities?

Read More »
medical devices

EUDAMED – update on timelines

EUDAMED is one of the key aspects of the new rules on medical devices (Regulation (EU) 2017/745) and in vitro diagnostic medical devices (Regulation (EU) 2017/746), and it is expected to achieve full functionality by the second quarter of 2024.

Read More »
cosmetic products

UK OPSS call for data on six cosmetic ingredients

On 14 July 2022, the Office for Product Safety and Standards (OPSS – the UK regulator for cosmetic products) issued a call for data on the safety of the following six cosmetic ingredients to investigate any suspected endocrine disrupting properties. 

Read More »
cosmetic products

European Commission Recommendation on the Definition of Nanomaterial

Nanomaterials are increasingly used in cosmetics and personal care products. They are similar to other chemicals/substances, but with specific risks associated to their use. The European Commission has published a new Recommendation to clarify the definition of ‘nanomaterial’. This definition may serve different policy, legislative and research purposes when addressing materials or issues concerning products of nanotechnologies.

Read More »
cosmetic products

Expected Restriction on the Use of Methyl Salicylate

The European Commission has notified the World Trade Organization (WTO) of a draft amendment to the Regulation (EC) No. 1223/2009 on cosmetic products. Annex III to Regulation will be amended, and the use of Methyl Salicylate in cosmetic products will be restricted.

Read More »
cosmetic products

Environmental Labelling of Cosmetic Products in Italy and France

Although the European Cosmetics Regulation is applicable to every cosmetic product made available in the European Union market, some national legislations may also apply. Environmental regulations in Italy and France specify mandatory labelling requirements applicable to products marketed in these countries.

Read More »